Scinovex
article Open AccessTop 1% cited

A Hierarchical Network of Interreceptor Interactions Determines Signal Transduction by Neu Differentiation Factor/Neuregulin and Epidermal Growth Factor

Molecular and Cellular Biology · 1996 · Vol. 16(10) · pp. 5276–5287
Eldad TzaharHadassa WatermanXiomei ChenGil LevkowitzDevarajan KarunagaranSara LaviBarry RatzkinYosef Yarden

Abstract

The ErbB family includes four homologous transmembrane tyrosine kinases. Whereas ErbB-1 binds to the epidermal growth factor (EGF), both ErbB-3 and ErbB-4 bind to the Neu differentiation factors (NDFs, or neuregulins), and ErbB-2, the most oncogenic family member, is an orphan receptor whose function is still unknown. Because previous lines of evidence indicated the existence of interreceptor interactions, we used ectopic expression of individual ErbB proteins and their combinations to analyze the details of receptor cross talks. We show that 8 of 10 possible homo-and heterodimeric complexes of ErbB proteins can be hierarchically induced by ligand binding. Although ErbB-2 binds neither ligand, even in a heterodimeric receptor complex, it is the preferred heterodimer partner of the three other members, and it favors interaction with ErbB-3. Selective receptor overexpression in human tumor cells appears to bias the hierarchical relationships. The ordered network is reflected in receptor transphosphorylation, ErbB-2-mediated enhancement of ligand affinities, and remarkable potentiation of mitogenesis by a coexpressed ErbB-2. The observed superior ability of ErbB-2 to form heterodimers, in conjunction with its uniquely high basal tyrosine kinase activity, may explain why ErbB-2 overexpression is associated with poor prognosis.

HER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies ResearchGlycosylation and Glycoproteins ResearchNeuregulinErbBBiologyReceptor tyrosine kinaseEpidermal growth factorERBB3ERBB4Cell biologyNeuregulin 1Signal transduction

MeSH terms

AnimalsCell LineDNAEpidermal Growth FactorGlycoproteinsCricetinaeHumansKineticsNerve Growth FactorsPhosphorylationProto-Oncogene ProteinsRadioligand AssayRecombinant ProteinsThymidineTransfection

Funding

  • Israel Cancer Research Fund
  • Israel Academy of Sciences and Humanities
  • National Cancer Institute
Citations
1,029
FWCI
19.46
field-weighted impact
References
63
Percentile
100%
vs. same field & year
Citations per year
Cited by
Epidermal growth factor receptors: critical mediators of multiple receptor pathways
Current Opinion in Cell Biology · 1999 · 607 citations
The EGFR family and its ligands in human cancer
European Journal of Cancer · 2001 · 1,573 citations
Untangling the ErbB signalling network
Nature Reviews Molecular Cell Biology · 2001 · 6,890 citations
Target Binding Properties and Cellular Activity of Afatinib (BIBW 2992), an Irreversible ErbB Family Blocker
Journal of Pharmacology and Experimental Therapeutics · 2012 · 858 citations
The deaf and the dumb: the biology of ErbB-2 and ErbB-3
Experimental Cell Research · 2003 · 588 citations
The ErbB receptors and their role in cancer progression
Experimental Cell Research · 2003 · 611 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.